Mitochondrial aldehyde dehydrogenase (ALDH2) as a new target for anti-atherosclerotic drugs

2011/01/N/NZ4/01145

Keywords

Descriptors

  • NZ4_17: Farmakologia
  • NZ2_3: Proteomika

Panel

NZ4 – Biology of tissues, organs and organisms: morphology and functions of animal's and human's systems, organs and organisms, experimental medicine, basics of neurology

Host institution

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

Aneta Olga Stachowicz

Number of co-investigators in the project: 2

Call

PRELUDIUM 1 – announced on 2011-03-15

Amount awarded
166 300 PLN
Project start date
2011-12-16
Project end date
2014-05-15
Project duration
29 months (the same as in the proposal)
Project status
Project settled

Equipment purchased [PL]

  1. MicroRotofor. Cost: 35 000 PLN

Information in the final report

Articles in post-conference publications (1)

  1. Proteomic analysis of liver mitochondria of atherosclerotic apoE-knockout mice treated with Alda-1 - an activator of mitochondrial aldehyde dehydrogenase (ALDH2)

    Authors:
    Aneta Stachowicz, Maciej Suski, Rafał Olszanecki, Józef Madej, Anna Wiśniewska, Jacek Jawień, Magdalena Białas, Krzysztof Okoń, Ryszard Korbut
    Conference:
    XVIIIth International Congress of the Polish Pharmacology (year: 2013, pages: 85-86), Publisher: Institute of Pharmacology Polish Academy of Sciences
    Date:
    conference 23-25 maja
    Status:
    Published

« New search

Graphic design and implementation: Jakub Piotrowski